BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 15188367)

  • 21. A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography.
    Salaffi F; Manganelli P; Carotti M; Baldelli S; Blasetti P; Subiaco S; Binci MC; Bichi Secchi E; Amici F; Cervini C
    Br J Rheumatol; 1998 Mar; 37(3):263-9. PubMed ID: 9566665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in Texture Analysis Parameters Between Active Alveolitis and Lung Fibrosis in Chest CT of Patients with Systemic Sclerosis: A Feasibility Study.
    Kloth C; Blum AC; Thaiss WM; Preibsch H; Ditt H; Grimmer R; Fritz J; Nikolaou K; Bösmüller H; Horger M
    Acad Radiol; 2017 Dec; 24(12):1596-1603. PubMed ID: 28807589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
    Giacomelli R; Valentini G; Salsano F; Cipriani P; Sambo P; Conforti ML; Fulminis A; De Luca A; Farina G; Candela M; Generini S; De Francisci A; Tirri E; Proietti M; Bombardieri S; Gabrielli A; Tonietti G; Cerinic MM
    J Rheumatol; 2002 Apr; 29(4):731-6. PubMed ID: 11950014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of alveolitis in interstitial lung manifestation in connective tissue diseases: importance of late inspiratory crackles, 67 gallium scan and bronchoalveolar lavage.
    Witt C; Dörner T; Hiepe F; Borges AC; Fietze I; Baumann G
    Lupus; 1996 Dec; 5(6):606-12. PubMed ID: 9116705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of interstitial lung disease (ILD) in patients with systemic sclerosis. The significance of broncho-alveolar lavage (BAL) --personal observations].
    Kopiński P; Korkosz M; Janowska E
    Folia Med Cracov; 1996; 37(3-4):51-66. PubMed ID: 9312535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function.
    Wallaert B; Hatron PY; Grosbois JM; Tonnel AB; Devulder B; Voisin C
    Am Rev Respir Dis; 1986 Apr; 133(4):574-80. PubMed ID: 3963625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis? Diagnostic role of high resolution Computed Tomography (HRCT).
    Zompatori M; Calabrò E; Chetta A; Chiari G; Marangio E; Olivieri D
    Radiol Med; 2003 Sep; 106(3):135-46. PubMed ID: 14612834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral bronchoalveolar lavage in progressive systemic sclerosis: interlobar variability, lymphocyte subpopulations, and functional correlations.
    Frigieri L; Mormile F; Grilli N; Mancini D; Ciappi G; Pagliari G; Magarò M; Flamini G
    Respiration; 1991; 58(3-4):132-40. PubMed ID: 1745844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-beta1 in bronchoalveolar lavage fluid in diffuse parenchymal lung diseases and high-resolution computed tomography score.
    Szlubowski A; Soja J; Grzanka P; Tomaszewska R; Papla B; Kuzdzał J; Cmiel A; Sładek K
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):270-5. PubMed ID: 20693957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases.
    Garcia JG; Wolven RG; Garcia PL; Keogh BA
    Am Rev Respir Dis; 1986 Mar; 133(3):444-9. PubMed ID: 3954253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease.
    Yilmaz N; Abul Y; Bicakcigil M; Golabi P; Celikel C; Karakurt S; Yavuz S
    Rheumatol Int; 2012 Jul; 32(7):1921-5. PubMed ID: 21448645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study.
    Frauenfelder T; Winklehner A; Nguyen TD; Dobrota R; Baumueller S; Maurer B; Distler O
    Ann Rheum Dis; 2014 Dec; 73(12):2069-73. PubMed ID: 25269829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis.
    Sfriso P; Cozzi F; Oliviero F; Caso F; Cardarelli S; Facco M; Fittà C; Del Rosso A; Matucci-Cerinic M; Punzi L; Agostini C
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S71-5. PubMed ID: 22691213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.
    Salaffi F; Carotti M; Di Donato E; Di Carlo M; Ceccarelli L; Giuseppetti G
    PLoS One; 2016; 11(3):e0149240. PubMed ID: 26930658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study.
    Highland KB; Silver RM
    Curr Rheumatol Rep; 2005 Apr; 7(2):135-41. PubMed ID: 15760593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.